{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:31:58Z","timestamp":1755217918088,"version":"3.43.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Infant botulism (IB) affects infants under 1 year of age, caused by the ingestion of <jats:italic toggle=\"yes\">Clostridium botulinum<\/jats:italic> spores and subsequent neurotoxin production. IB is rare in Europe. This study aimed to analyze the epidemiology and management of IB over the past 25 years in Southern Spain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective, multicenter study of IB cases detected in Andalusia since 1997. Epidemiologic, clinical, diagnostic and outcome variables were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-three patients from 7 different hospitals were included, with a median age of 3 months. Most of these patients presented with weak crying, constipation, arreactive mydriasis and loss of myotatic reflexes. Neurophysiological studies showed alterations in 74% of the cases at diagnosis. The diagnosis was confirmed in all cases by stool sample analysis. Only 4 patients received human botulism immunoglobulin (HBIG) and 10 received empirically intravenous immunoglobulin (IVIG). The median time to improvement in patients who received IVIG and HBIG was slightly shorter; however, no differences were observed. Significant differences were observed when IVIG was administered within the first 72 hours (14 vs. 25 days, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.035). In addition, patients who received empirical antimicrobial therapy required longer hospitalization times secondary to observed exacerbated paralysis (20 vs. 12 days, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.033).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IVIG may be an effective treatment for shortening the duration of illness in regions that are not readily accessible for HBIG, but further studies are needed. Although IB is rare, when it is suspected, antimicrobial therapy should be avoided as it may exacerbate paralysis by increasing the availability of neurotoxin for absorption.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004727","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T17:02:01Z","timestamp":1737133321000},"page":"e193-e198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Could Intravenous Immunoglobulin Be an Alternative Therapy for Treating Infant Botulism in Areas Where Human Botulism Immunoglobulin Is Not Easily Available?: Our Experience in Andalusia, Spain"],"prefix":"10.1097","volume":"44","author":[{"given":"Laura","family":"Palomino-Fernandez","sequence":"first","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Reina Sofia University Hospital, Cordoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Villarejo-Perez","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Rheumatology and Immunology and Unit, Virgen del Rocio University Hospital, IBIS, Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Fernandez-Fuentes","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Rheumatology and Immunology and Unit, Virgen del Rocio University Hospital, IBIS, Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Sanchez-Codez","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Puerta del Mar Universito Hospital, Cadiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorelain","family":"Del Valle-De Leon","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Reina Sofia University Hospital, Cordoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gallego-Gutierrez","sequence":"additional","affiliation":[{"name":"General Pediatric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrella","family":"Peromingo-Matute","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Puerta del Mar Universito Hospital, Cadiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Carazo-Gallego","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department, Malaga University Regional Hospital, M\u00e1laga"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"L\u00f3pez-Laso","sequence":"additional","affiliation":[{"name":"Paediatric Neurology Unit, Reina Sofia University Hospital, IMIBIC, CIBERER, Cordoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cano-Cabrera","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Virgen Macarena University Hospital, Seville, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola","family":"Falcon-Neyra","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Rheumatology and Immunology and Unit, Virgen del Rocio University Hospital, IBIS, Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Rheumatology and Immunology and Unit, Virgen del Rocio University Hospital, IBIS, Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-6438","authenticated-orcid":false,"given":"Beatriz","family":"Ruiz-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Reina Sofia University Hospital, Cordoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the GAIP (Grupo Andaluz de Infectolog\u00eda e Inmunopatolog\u00eda Pedi\u00e1trica) Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3201\/eid2902.220991","article-title":"Infant botulism, Israel, 2007\u20132021.","volume":"29","author":"Goldberg","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pediatrneurol.2015.01.006","article-title":"Infant botulism: review and clinical update.","volume":"52","author":"Rosow","year":"2015","journal-title":"Pediatr Neurol"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7002a1","article-title":"Clinical guidelines for diagnosis and treatment of botulism, 2021.","volume":"70","author":"Rao","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1157\/13120050","article-title":"Infant botulism.","volume":"68","author":"L\u00f3pez Laso","year":"2008","journal-title":"An Pediatr (Engl Ed)"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2007-1827","article-title":"Global occurrence of infant botulism, 1976\u20132006.","volume":"122","author":"Koepke","year":"2008","journal-title":"Pediatrics"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa051926","article-title":"Human botulism immune globulin for the treatment of infant botulism.","volume":"354","author":"Arnon","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/toxins12110716","article-title":"Toxemia in human naturally acquired botulism.","volume":"12","author":"Rasetti-Escargueil","year":"2020","journal-title":"Toxins (Basel)"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.19.2.298-314.2006","article-title":"Laboratory diagnostics of botulism.","volume":"19","author":"Lindstro\u0308m","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0950268813001258","article-title":"Infant botulism with prolonged faecal excretion of botulinum neurotoxin and Clostridium botulinum for 7 months.","volume":"142","author":"Derman","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/088307389400900404","article-title":"Topical review: electrodiagnosis of infantile botulism.","volume":"9","author":"Gutierrez","year":"1994","journal-title":"J Child Neurol"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/(SICI)1097-4598(199910)22:10<1388::AID-MUS8>3.0.CO;2-3","article-title":"Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG.","volume":"22","author":"Padua","year":"1999","journal-title":"Muscle Nerve"},{"key":"R13-20250805","article-title":"Infant Botulism Treatment and Prevention Program."},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpeds.2017.12.002","article-title":"BabyBIG has BIG advantages for treatment of infant botulism.","volume":"193","author":"Long","year":"2018","journal-title":"J Pediatr"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/toxins15010002","article-title":"Botulism in Spain: epidemiology and outcomes of antitoxin treatment, 1997\u20132019.","volume":"15","author":"Pe\u00f1uelas","year":"2022","journal-title":"Toxins (Basel)"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin.","volume":"69","author":"Black","year":"1980","journal-title":"Am J Med"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/0883073808318200","article-title":"Infant botulism: two recent cases and literature review.","volume":"23","author":"Domingo","year":"2008","journal-title":"J Child Neurol"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/AAC.01594-18","article-title":"Antimicrobial susceptibility of 260 Clostridium botulinum type A, B, Ba, and Bf strains and a neurotoxigenic Clostridium baratii type F strain isolated from California infant botulism patients.","volume":"62","author":"Barash","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpn.2013.12.008","article-title":"Infant botulism in Andalusia (Southern Spain).","volume":"18","author":"L\u00f3pez-Laso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.me.31.020180.002545","article-title":"Infant botulism.","volume":"31","author":"Arnon","year":"1980","journal-title":"Annu Rev Med"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00284-024-03828-0","article-title":"Infant botulism: in search of Clostridium botulinum spores.","volume":"81","author":"Harris","year":"2024","journal-title":"Curr Microbiol"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpeds.2009.09.072","article-title":"Presence of soil-dwelling clostridia in commercial powdered infant formulas.","volume":"156","author":"Barash","year":"2010","journal-title":"J Pediatr"},{"key":"R24-20250805","first-page":"828","article-title":"Risk factors for infant botulism in the United States.","volume":"143","author":"Spika","year":"1989","journal-title":"Am J Dis Child"},{"key":"R26-20250805","doi-asserted-by":"crossref","first-page":"322","DOI":"10.14745\/ccdr.v47i78a05","article-title":"A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979\u20132019.","volume":"47","author":"Harris","year":"2021","journal-title":"Can Commun Dis Rep"},{"key":"R27-20250805","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2017.10.035","article-title":"Efficacy of human botulism immune globulin for the treatment of infant botulism: the first 12 years post licensure.","volume":"193","author":"Payne","year":"2018","journal-title":"J Pediatr"},{"key":"R28-20250805","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/cid\/ciz515","article-title":"Safety and clinical outcomes of an equine-derived heptavalent botulinum antitoxin treatment for confirmed or suspected botulism in the United States.","volume":"70","author":"Richardson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R29-20250805","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1128\/CVI.05261-11","article-title":"Equine botulinum antitoxin for the treatment of infant botulism.","volume":"18","author":"Vanella de Cuetos","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R30-20250805","first-page":"28","article-title":"Evolution of the immune system in humans from infancy to old age.","volume":"22","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"R31-20250805","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12016-015-8499-2","article-title":"Impact of immunoglobulin therapy in pediatric disease: a review of immune mechanisms.","volume":"51","author":"Wong","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R32-20250805","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/23744235.2021.1919753","article-title":"Infant botulism: an underestimated threat.","volume":"53","author":"Antonucci","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"R33-20250805","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2807\/1560-7917.ES.2017.22.24.30550","article-title":"Botulism in Italy, 1986 to 2015.","volume":"22","author":"Anniballi","year":"2017","journal-title":"Euro Surveill"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:05:42Z","timestamp":1754427942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004727","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"type":"print","value":"0891-3668"},{"type":"electronic","value":"1532-0987"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}